Emerging drugs of abuse: current perspectives on synthetic cannabinoids
Abstract New psychoactive drugs that have appeared over the last decade are typically dominated by cathinones and synthetic cannabinoids (SCs).…
novel synthetic cannabinoids (NSCs)
Designer drugs 2015: assessment and management
Abstract Recent designer drugs, also known as “legal highs,” include substituted cathinones (e.g., mephedrone, methylone, and methylenedioxypyrovalerone, often referred to…
Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches
Abstract Synthetic cannabinoids (CBs) such as the JWH series have caused social problems concerning their abuse liability. Because the JWH…
Gone to Pot – A Review of the Association between Cannabis and Psychosis
Abstract Cannabis is the most commonly used illicit drug worldwide, with ~5 million daily users worldwide. Emerging evidence supports a…